• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理性设计新型苯并恶唑啉合酶抑制剂:化学合成与生物学评价加速新型抗分枝杆菌抗生素的发现。

Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics.

机构信息

Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215, India.

Mycobacteria Research Laboratory, School of Natural Sciences, Institute of Structural and Molecular Biology, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK.

出版信息

Molecules. 2023 Dec 15;28(24):8115. doi: 10.3390/molecules28248115.

DOI:10.3390/molecules28248115
PMID:38138601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10745776/
Abstract

The uncontrolled spread of drug-resistant tuberculosis (DR-TB) clinical cases necessitates the urgent discovery of newer chemotypes with novel mechanisms of action. Here, we report the chemical synthesis of rationally designed novel transition-state analogues (TSAs) by targeting the cyclization (Cy) domain of phenyloxazoline synthase (MbtB), a key enzyme of the conditionally essential siderophore biosynthesis pathway. Following bio-assay-guided evaluation of TSA analogues preferentially in iron-deprived and iron-rich media to understand target preferentiality against a panel of pathogenic and non-pathogenic mycobacteria strains, we identified a hit, i.e., . Molecular docking, dynamics, and MMPBSA calculations enabled us to comprehend 's stable binding at the active site pocket of and the results imply that the binding pocket has a strong affinity for electron-withdrawing functional groups and contributes to stable polar interactions between enzyme and ligand. Furthermore, enhanced intracellular killing efficacy (8 μg/mL) of against in infected macrophages is noted in comparison to moderate in vitro antimycobacterial efficacy (64 μg/mL) against . also demonstrates whole-cell efflux pump inhibitory activity against . Identification of by focusing on the modular domain paves the way for accelerating novel anti-TB antibiotic discoveries.

摘要

耐药结核病(DR-TB)临床病例的失控传播需要紧急发现具有新型作用机制的新型化学型。在这里,我们报告了通过针对苯并恶唑啉合酶(MbtB)的环化(Cy)结构域,合理设计的新型过渡态类似物(TSA)的化学合成,MbtB 是条件必需的铁载体生物合成途径的关键酶。在缺铁和富铁培养基中进行生物测定指导的 TSA 类似物的评估,以了解针对一系列致病性和非致病性分枝杆菌菌株的靶标偏好性之后,我们确定了一个命中物,即 。分子对接、动力学和 MMPBSA 计算使我们能够理解 在 和结果表明, 结合口袋对吸电子官能团具有很强的亲和力,并有助于酶和配体之间的稳定极性相互作用。此外,与体外对 的中度抗分枝杆菌功效(64 μg/mL)相比, 在感染的巨噬细胞中对 的细胞内杀伤功效(8 μg/mL)得到增强。 还显示出针对整个细胞外排泵的抑制活性。通过关注模块化 结构域来鉴定 ,为加速新型抗结核抗生素的发现铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/2629b6331f17/molecules-28-08115-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/25ec98acf387/molecules-28-08115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/2a60474f898b/molecules-28-08115-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/3631c567d42c/molecules-28-08115-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/0b31bd6fe57e/molecules-28-08115-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/1c4ebdaebf5b/molecules-28-08115-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/c25512ca5d5a/molecules-28-08115-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/36490095dbe8/molecules-28-08115-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/2eee478120f6/molecules-28-08115-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/2629b6331f17/molecules-28-08115-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/25ec98acf387/molecules-28-08115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/2a60474f898b/molecules-28-08115-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/3631c567d42c/molecules-28-08115-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/0b31bd6fe57e/molecules-28-08115-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/1c4ebdaebf5b/molecules-28-08115-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/c25512ca5d5a/molecules-28-08115-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/36490095dbe8/molecules-28-08115-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/2eee478120f6/molecules-28-08115-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c37e/10745776/2629b6331f17/molecules-28-08115-g007.jpg

相似文献

1
Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics.理性设计新型苯并恶唑啉合酶抑制剂:化学合成与生物学评价加速新型抗分枝杆菌抗生素的发现。
Molecules. 2023 Dec 15;28(24):8115. doi: 10.3390/molecules28248115.
2
Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria.结核分枝杆菌 Pks13、PknG 与极端微生物活性成分相互作用的分子对接、分子动力学模拟及结合自由能研究。
Sci Rep. 2024 Mar 21;14(1):6794. doi: 10.1038/s41598-024-57124-9.
3
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.社论:结核杆菌药物靶点的现状与展望以及基于构效关系的抗结核药物设计
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
4
Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.抗结核化合物库筛选鉴定出新型结核分枝杆菌ATP合酶抑制剂。
Tuberculosis (Edinb). 2018 Jan;108:56-63. doi: 10.1016/j.tube.2017.10.008. Epub 2017 Oct 25.
5
Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.通过基于结构的虚拟筛选、抗结核活性和分子动力学模拟,鉴定新型苯甲酰胺抑制剂对结核分枝杆菌色氨酸合酶α亚基的抑制作用。
J Biomol Struct Dyn. 2019 Mar;37(4):1043-1053. doi: 10.1080/07391102.2018.1448303. Epub 2018 Mar 13.
6
Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.鉴定一种新型异柠檬酸裂解酶抑制剂作为针对活性和非复制性结核分枝杆菌的强效抗结核药物。
Tuberculosis (Edinb). 2016 Mar;97:38-46. doi: 10.1016/j.tube.2015.12.003. Epub 2016 Jan 6.
7
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
8
Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria.分枝杆菌中 11H-吡啶并[2,1-b]喹唑啉-11-酮类似物的外排泵抑制作用。
Bioorg Med Chem. 2018 Sep 15;26(17):4942-4951. doi: 10.1016/j.bmc.2018.08.034. Epub 2018 Aug 29.
9
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
10
Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we stand.针对分枝杆菌生物合成途径的新型抗结核药物发现方法:我们的现状。
Expert Opin Drug Discov. 2022 Jul;17(7):699-715. doi: 10.1080/17460441.2022.2077328. Epub 2022 May 29.

引用本文的文献

1
Pyrazinamide-based Co(II), Ni(II) and Cu(II) complexes: DFT exploration of structure, reactivity properties and in silico ADMET profiles.基于吡嗪酰胺的钴(II)、镍(II)和铜(II)配合物:结构、反应性质及计算机辅助ADMET特性的密度泛函理论研究
J Mol Model. 2024 Nov 22;30(12):410. doi: 10.1007/s00894-024-06202-w.

本文引用的文献

1
Bottlenecks and opportunities in antibiotic discovery against Mycobacterium tuberculosis.抗结核分枝杆菌抗生素药物研发的瓶颈与机遇。
Curr Opin Microbiol. 2022 Oct;69:102191. doi: 10.1016/j.mib.2022.102191. Epub 2022 Aug 12.
2
Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we stand.针对分枝杆菌生物合成途径的新型抗结核药物发现方法:我们的现状。
Expert Opin Drug Discov. 2022 Jul;17(7):699-715. doi: 10.1080/17460441.2022.2077328. Epub 2022 May 29.
3
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition.
具有优异药代动力学特性的分枝杆菌霉素类似物表现出强大的抗结核特异性活性和卓越的外排泵抑制作用。
J Med Chem. 2022 Jan 13;65(1):234-256. doi: 10.1021/acs.jmedchem.1c01349. Epub 2022 Jan 4.
4
The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis.分枝杆菌霉素生物合成途径:抗结核治疗的潜在靶点。
J Med Chem. 2021 Jan 14;64(1):71-100. doi: 10.1021/acs.jmedchem.0c01176. Epub 2020 Dec 29.
5
Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes.莱索托利福平耐药结核病:诊断、治疗启动和结局。
Sci Rep. 2020 Feb 5;10(1):1917. doi: 10.1038/s41598-020-58690-4.
6
Large-Scale Chemical-Genetic Strategy Enables the Design of Antimicrobial Combination Chemotherapy in .大规模化学遗传学策略助力抗菌联合化疗方案的设计 。 你提供的原文似乎不完整,句末的“in.”后面应该还有具体内容。
ACS Infect Dis. 2020 Jan 10;6(1):56-63. doi: 10.1021/acsinfecdis.9b00373. Epub 2019 Nov 28.
7
The Immune Escape Mechanisms of .的免疫逃逸机制。
Int J Mol Sci. 2019 Jan 15;20(2):340. doi: 10.3390/ijms20020340.
8
CASTp 3.0: computed atlas of surface topography of proteins.CASTp 3.0:蛋白质表面形貌计算图谱。
Nucleic Acids Res. 2018 Jul 2;46(W1):W363-W367. doi: 10.1093/nar/gky473.
9
Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis.构象受限的噌啉酮核苷类似物作为结核病铁载体生物合成抑制剂
ACS Med Chem Lett. 2018 Mar 16;9(4):386-391. doi: 10.1021/acsmedchemlett.8b00090. eCollection 2018 Apr 12.
10
LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands.LigParGen 网络服务器:一种用于有机配体的自动 OPLS-AA 参数生成器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W331-W336. doi: 10.1093/nar/gkx312.